Skip to content

Clinical trials

Phase 3 Respiration Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiration Disorders Phase: Phase 3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20204
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bellus Health Inc. - a GSK company2
Merck Sharp & Dohme LLC2
Adrian Hernandez1
Assistance Publique - Hôpitaux de Paris1
Consorcio Centro de Investigación Biomédica en Red (CIBER)1
R-Pharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiration Disorders8
Respiratory Tract Diseases5
Chronic Cough4
Cough4
Signs and Symptoms, Respiratory4
COVID-192
Lung Diseases2
Respiratory Distress Syndrome2
Signs and Symptoms2
Acute Lung Injury1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.